Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total

Not Applicable (1)

P 4 (1)

Trial Status

Completed3

Withdrawn1

Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (5)

Showing 5 of 5 trials

NCT03067350Completed

Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients

NCT01976078Completed

Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents

NCT03260634UnknownPrimary

The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.

NCT02110316Phase 4WithdrawnPrimary

Bioavailability of Voriconazole

NCT01344512Not ApplicableCompleted

Population Pharmacokinetics of Anti-infectious Drugs in Children

Showing all 5 trials

Voriconazole